Somatostatin Injection

  • peptide hormone


Somatostatin Injection is a peptide hormone, prescribed for gastrointestinal hemorrhage. Somatostatin (also known as growth hormone-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) or somatotropin release-inhibiting hormone is a peptide harmone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein – coupled somatostatin and inhibition of the release of numerous secondary hormones. Somatostatin is used in treatment of severe acute gastrointestinal hemorrhage, resulting from gastric or duodenal ulcers, hemorrhagic gastritis and esophageal varices, biliary and pancreatic fistulae.

India has many manufacturers who manufacture Somatostatin Injection .To know more contact us.

3s corporation is Supplier,Exporter ,Wholesaler  for Somatostatin Injection in India.

Additional Information

Somatostatin Injection is contraindicated in Hypersensitivity.

Side Effects

Cardiac Disorders: atrioventricular block, bradycardia, arrhythmia, ventricular extrasystole.

Gastrointestinal Disorders: abdominal pain, diarrhea, nausea, vomiting.

Metabolism and Nutrition Disorders: hyperglycaemia, hypoglycaemia.

Vascular Disorders: hypertension, hypotension, hot flushes.

Abrupt interruption of continuous infusion may result in a rebound effect of the treated disease, especially in patients treated for fistula.

Pack Size